Global Ophthalmology Market Size to Exceed USD 147.87 Billion by 2035 | CAGR of 6.27%

Global Ophthalmology Market Size to Exceed USD 147.87 Billion by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Global Ophthalmology Market Size is expected to Grow from USD 75.71 Billion in 2024 to USD 147.87 Billion by 2035, at a CAGR of 6.27% during the forecast period 2025-2035.  

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Ophthalmology Market Size, Share, and COVID-19 Impact Analysis, By Product (Device, Drugs, and Others), By Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), By Route of Administration (Oral, Topical, Injectable, Local Ocular, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. Get Detailed Report Description Here: https://www.decisionsadvisors.com/reports/ophthalmology-market                 

The ophthalmology market is an extensive field focused on the research, diagnosis, and treatment of eye diseases and conditions. It encompasses eye surgery, optometry, and vision science research, along with various other medical specialities. The sector addresses issues like cataracts, glaucoma, refractive errors, and retinal diseases, focusing on eye health and wellness. Additionally, through ongoing research, innovation, and medical care, the industry is essential in preserving and restoring sight, enhancing quality of life, and decreasing vision-related conditions. The market is dedicated to improving patient results, promoting visual health, and adapting to evolving technologies and treatment methods as an essential aspect of healthcare. The demand for ophthalmology is growing due to two key factors converging: the prevalence of eye issues and increased healthcare awareness among individuals globally. The growth potential is present in emerging regions, supported by heightened awareness and improved affordability. AI-driven diagnostics, regenerative treatments, and monitoring technologies worn on the body are transforming efficiency, accuracy, and preventive healthcare. However, the ophthalmology industry suffers from serious obstacles due to high treatment costs that limit patient access and delay treatments, with strict regulatory processes also lengthening product approvals and raising operating costs.

The drugs segment accounted for a significant share in 2024 and is projected to grow at a rapid pace over the forecast period.       

Based on the product, the ophthalmology market is divided into device, drugs, and others. Among these, the drugs segment accounted for a significant share in 2024 and is projected to grow at a rapid pace over the forecast period. Ophthalmic drugs treat a variety of eye conditions, including inflammation, infections, macular degeneration, and glaucoma. Personalised therapeutics, gene-based treatments, and enhanced medication efficacy are examples of emerging innovations.

The glaucoma segment accounted for a substantial share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.       

Based on the disease, the ophthalmology market is segmented into glaucoma, cataract, age-related macular degeneration, inflammatory diseases, refractive disorders, and others. Among these, the glaucoma segment accounted for a substantial share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Advances in diagnostic tools, such as pressure monitoring devices and innovative imaging technology, enable ophthalmologists to detect glaucoma at an early stage, enhancing treatment and preventing irreversible vision loss.

The local ocular segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the route of administration, the ophthalmology market is classified into oral, topical, injectable, local ocular, and others. Among these, the local ocular segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. By delivering drugs directly to the site of action, it increases therapy efficacy while lowering systemic side effects.

Asia Pacific is expected to hold the majority share of the global ophthalmology market during the forecast period.       

Asia Pacific is expected to hold the majority share of the global ophthalmology market during the forecast period. The need for various eye care services is expected to increase due to the rising incidence of vision-related problems and an ageing population. It is anticipated that countries like China and India will invest heavily in healthcare infrastructure, increasing access to state-of-the-art ophthalmic technologies.

North America is anticipated to grow at the fastest pace in the global ophthalmology market during the forecast period. The North American ophthalmology market is experiencing a robust trend as a result of increased healthcare spending, technological developments, and advanced healthcare infrastructure. The high prevalence of eye diseases in the area, particularly those related to ageing, has increased demand for ophthalmic diagnostics and treatments.

Major vendors in the global ophthalmology market are Alkem Laboratories, Bausch+Lomb, Carl Zeiss Meditec AG, Essilor International S.A., Haag-Streit AG, Hoya Corporation, Iridex Corporation, Lumenis Ltd., NIDEK CO., LTD., Novartis AG, Optovue, Inc. (A Subsidiary of Carl Zeiss Meditec AG), STAAR Surgical Company, Topcon Corporation, Ziemer Ophthalmic Systems AG, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development   

• In December 2025, the Emirates Society of Ophthalmology (ESO) and Bascom Palmer Eye Institute Abu Dhabi inked a historic strategic alliance to promote ophthalmic clinical practice, research, and teaching throughout the United Arab Emirates. Along with a formal agreement, the event signalled the start of a cooperative effort to improve ophthalmic research, teaching, and clinical standards across the United Arab Emirates.

Market Segment 

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors and Consulting has segmented the Ophthalmology market based on the below-mentioned segments: 

Global Ophthalmology Market, By Product

• Device
• Drugs
• Others

Global Ophthalmology Market, By Disease

• Glaucoma
• Cataract
• Age-Related Macular Degeneration
• Inflammatory Diseases
• Refractive Disorders
• Others

Global Ophthalmology Market, By Route of Administration

• Oral
• Topical
• Injectable
• Local Ocular
• Others

Global Ophthalmology Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa